There is mixed evidence that CSF total/p-tau levels may be lower in PCA-AD than typical AD despite comparable CSF Aβ1–42 [6, 48, 49], raising the possibility that in some instances these ratios may be less elevated in PCA than typical AD [30•]. Here, MAPT is linked to Alzheimer disease.